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Summary
INTRODUCTION: Infertility treatments are a major
source of the increase in multiple pregnancies (MPs).
AIMS: The aims of the present study were (1.) to investig-
ate the origin and maternal/neonatal outcomes of MP and
(2.) to review the different measures that can be adopted to
reduce these serious complications.
METHODS: The study included all women with multiple
births between 1 January 1995 and 31 December 2006
at the University Hospital of Bern, Switzerland. The out-
comes associated with the various origins of MP (natural
conception, ovarian stimulation [OS] ‒ in-vitro fertilisation
[IVF-ICSI]) were analysed using a multinomial logistic re-
gression model.
An analysis of the Swiss law on reproductive medicine and
its current proposed revision, as well as a literature review
using Pubmed, was carried out.
RESULTS: A total of 592 MP were registered, 91% (n =
537) resulted in live births. There was significantly more
neonatal/maternal morbidity in MP after OS compared
with natural conception and even with the IVF-ICSI group.
With a policy of elective single embryo transfer (eSET),
twin rates after IVF-ICSI can be reduced to <5% and
triplets to <1%.
CONCLUSIONS: After OS, more triplets are found and
the outcome of MP is worse. MP is known to be associated
with morbidity, mortality, and economic and social risks.
To counteract these complications (1.) better training for
physicians performing OS should be encouraged and (2.)
the Swiss law on reproductive medicine needs to be
changed, with the introduction of eSET policies. This
would lead to a dramatic decrease in neonatal and maternal
morbidity/mortality as well as significant cost reductions
for the Swiss healthcare system.
Key words: ovarian stimulation; infertility treatment; IVF-
ICSI; intrauterine insemination; multiple pregnancies;
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Introduction
In recent decades, the number of twins and triplets has been
continually rising with a simultaneously decreasing birth
rate. In Switzerland, the incidence of twin deliveries in-
creased from 127.6 per 10,000 (1.3% of all live births) in
1996 to 160 per 10,000 (1.6% of all live births) in 2004.
This is equivalent to a rise of 25% in only 8 years. In con-
trast to this, the number of live births per 1,000 inhab-
itants in the same study period (1995 to 2006), declined
from 11.7 to 9.8 [1]. But these observations are not spe-
cific to Switzerland. A summary of studies from different
European countries and North America show that, for ex-
ample, in France twin deliveries increased between 1972
and 1998 from 8.9 per 1,000 deliveries to 14.4 which is
equivalent to an increase of 62% [2]. In contrast to the con-
tinually rising occurrence of twins, the rise in triplet de-
liveries is phenomenal. Again in France, in addition to the
62% increase in twins, a rise of 310% for triplets (0.09 per
1,000 live births in 1972 and 0.33 in 1989) was observed
[2].
Multiple pregnancies (MP) have serious adverse effects on
neonatal and maternal health, such as increased morbidity
(physically, psychologically) and mortality as well as social
and economic consequences. Maternal mortality rates rise
two to three fold in women with multiple pregnancies [3].
In some studies, the risk of depression even several years
after delivery is very high [2, 4–6]. There is also a high di-
vorce rate among multiple birth parents [7]. Furthermore,
the economic consequences of multiple births due to infer-
tility treatments are substantial: [8]. Nearly all triplets are
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born with a birth weight below 2,500 g and the risk of hav-
ing a birth weight under 1,500 g increases with twin and
triplet pregnancies [2]. Low birth weight is associated with
increased adult incidence of cardiovascular disease and as-
sociated disorders such as hypertension and diabetes mel-
litus. The future costs of these complications also should
not be neglected. Moreover, premature birth and low birth
weight are associated with a lower rate of reproduction in
adulthood [9–11]. The risk of cerebral palsy in MP is also
increased [12] and the foetal anomaly rate (minor and ma-
jor) is known to be significantly higher in twin compared to
singleton pregnancies [13, 14]. Moreover, not only morbid-
ity but mortality is also substantially increased (intrauterine
death, neonatal mortality, infant mortality) [2]. The most
important causal factor for the rise in multiples is infertil-
ity treatment [2]. Infertility affects 10–15% of couples and
nowadays, 1% to 4% of the newborn are conceived due
to assisted reproductive technologies (ART) [14]. Two dif-
ferent forms of infertility treatments are specified: ovari-
an stimulation with/without intrauterine insemination (OS)
and in-vitro fertilisation (IVF) – intracytoplasmic sperm in-
jection (ICSI).
OS has already been in use since the seventies. The most
frequently used therapies to enhance oocyte maturation are
anti-oestrogen clomifene and/or gonadotrophins. However,
due to inappropriate application of these treatments, quad-
ruplets and quintuplets were already occurring in the sev-
enties [1]. In the USA, there are approximately 12% twin
pregnancies after IVF–ICSI, 21% after ovarian stimulation
(with/without IUI) and 67% after natural conception [15].
Unfortunately, in most countries (including Switzerland), a
national register exists for IVF-ICSI treatments only, but
not for OS. Consequently, precise outcomes of these ther-
apies are unknown.
In Switzerland, IVF-ICSI treatments as well as sperm
donation are regulated by the Swiss Law of Reproductive
Medicine [16]. Embryo cryopreservation is forbidden; only
fertilised oocytes in the pronuclear stage can be cryopre-
served. Up to three embryos can be transferred according
to the Swiss law. A change of certain articles of the Swiss
law is currently under discussion.
The aims of the present study were (1.) to investigate the
origin and the maternal/neonatal outcomes of MP in the
different groups and (2.) to review the different measures
that can be adopted to reduce these serious complications
of OS and IVF-ICSI treatments.
Materials and methods
Study design and study population
This is a retrospective cohort study that was approved by
the local ethics committee. All registered multiple deliver-
ies between 1 January 1995 and 31 December 2006 at the
University Hospital Bern, Department of Obstetrics, were
included.
Methods
Data were collected exclusively at the University Hospital
Bern, Department of Obstetrics. A total of 592 MP were re-
gistered during the study period. Ninety one percent were
Table 1: Characteristics of the mothers and maternal outcome according to the different modes of conception.
Factors Natural conception
(NC)
Ovarian stimulation (OS) IVF-ICSI (IVF) OS vs NC
RRR CI (95%)
VF vs NC
RRR CI (95%)
Mother General Characteristics
Number of patients, n (%)
Total n = 537 (100%)
391 (72.8) 60 (11.2) 86 (16)
Age, mean (SD) 30.8 (4.8) 30.7 (5) 32.8 (3.9) 0.99 [0.93–1.05] 1.1 [1.04–1.16]
BMI, mean (SD) 23.2 (4.35) 24.86 (6.56) 22.73 (3.53) 1.07 [1.01–1.13] 0.97 [0.91–1.04]
Multiparity (≥2), n (%) 232 (61.5) 22 (40) 31 (38.3) 2.4 [1.35–4.28] 2.58 [1.58–4.23]
Maternal outcomes during pregnancy
Mean gestational age at delivery
(wk), mean (SD)
33.59 (3.6) 31.9 (4.3) 33.04 (4) 0.89 [0.83–0.96] 0.96 [0.90–1.02]
Gestational diabetes, n (%) 9 (2.3) 2 (3.4) 5 (5.8) 1.49 [0.31–7.07] 2.62 [0.86–8.02]
Arterial hypertension, pre-
eclampsia, n (%)
44 (11.3) 7 (11.9) 11 (12.8) 1.06 [0.45–2.48] 1.16 [0.57–2.34]
Vaginal bleeding / placenta
praevia, n (%)
49 (12.5) 13 (22.0) 17 (19.8) 1.97 [0.99–3.91] 1.71 [0.93–3.16]
Preterm labour, premature
rupture of membranes, n (%)
257 (65.7) 45 (76.3) 58 (67.4) 1.68 [0.88–3.16] 1.08 [0.66–1.78]
Intrauterine growth restriction, n
(%)
59 (15.1) 8 (13.6) 6 (7) 0.88 [0.39–1.95] 0.42 [0.18–1.01]
Intrauterine death, n (%) 15 (3.8) 3 (5.1) 5 (5.8) 1.34 [0.37–4.79] 1.54 [0.54–4.38]
Amnion infection syndrome, n
(%)
29 (7.4) 16 (27.1) 10 (11.6) 4.64 [2.34–9.24] 1.64 [0.77–3.51]
Transfusion syndrome, n (%) 34 (8.7) 3 (5.1) 2 (2.3) 0.56 [0.16–1.89] 0.25 [0.06–1.06]
Cerclage, n (%) 9 (2.3) 1 (1.7) 1 (1.2) 0.73 [0.09–5.88] 0.49 [0.06–3.99]
Antibiotic treatment during
pregnancy, n (%)
109 (27.9) 17 (28.8) 33 (38.4) 1.05 [0.57–1.92] 1.61 [0.99–2.62]
Duration of hospitalisation
(days), mean (SD)
13.6 (11.5) 16.4 (12.7) 15.5 (12.8) 1.02 [0.99–1.04] 1.01 [0.99–1.03]
Caesarean section, n (%) 303 (77.9) 48 (82.8) 70 (82.4) 1.36 [0.66–2.80] 1.32 [0.72–2.43]
BMI = body mass index; CI = confidence interval; RRR = relative ride ratio SD = standard deviation
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twins, 8.4% triplets and 0.6% quadruplets. All MP with
live births (91%, n = 537), more precisely 489 twin-, 45
triplet- and 3 quadruplet-pregnancies, were included in the
analysis. Medical data were collected from patients’ notes.
Since the mode of conception was not always noted in the
medical records, couples were contacted by letter and re-
quested to complete a questionnaire (mode of conception,
type of infertility treatment undertaken, if any embryo re-
duction had been carried out or not).
The recorded data included maternal age, gestation and
parity, pre-existent maternal diseases (diabetes, hypertonia,
renal diseases, etc.), history of infertility treatments/em-
bryo reductions, pregnancy complications (past and
present), medication intake and toxic agents, mode of de-
livery, neonatal data with possible postnatal disease and
therapies.
An analysis of the Swiss law on reproductive medicine and
the proposal of the current revision as well as a literature
review using Pubmed was carried out.
Statistical analysis
The statistical data analysis was performed using STATA
12.1 (College Station, Texas 77845 USA). Continuous
variables were summarised as mean (SD) and as number
(percentage) for categorical data. Comparison of the group
“IVF-ICSI” and the group “OS” with the reference group
“natural conception” was performed using a multinomial
logistic regression analysis. A univariate analysis was done
to assess the association of maternal/neonatal factors to the
outcome. Significant predictors at the level of 20% were
used in a backward procedure to fit a multivariate model.
Results
Characteristics of the mothers and maternal outcome
according to the different modes of conception
These are depicted in table 1.
Compared with women in the natural conception group,
maternal age was significantly higher only in women un-
dergoing IVF-ICSI. Interestingly, BMI was significantly
higher in the OS than in the natural conception group.
In addition, parity was significantly different between the
groups: nulliparity was more common in the OS and IVF-
ICSI treatment groups. It should be noted that, compared
with the natural conception group, gestational age was sig-
nificantly lower and amniotic infection syndrome signific-
antly higher only in the OS, but not in the IVF-ICSI group.
No significant differences were detected between the two
groups for all the other pathologies listed in table 1.
Neonatal outcome according to the different modes of
conception
Details are illustrated in table 2.
The number of children was significantly higher after con-
ception by infertility treatments compared with natural
conception.
Table 2: Neonatal outcome according to the different modes of conception.
Neonatal outcome Natural conception
(NC)
Ovarian stimulation (OS) IVF-ICSI
(IVF)
OS vs NC
RRR CI (95%)
IVF vs NC
RRR CI (95%)
Number of pregn. n (%):
Twins . n (%)
Triplets . n (%)
Quadruplets . n (%)
391 (100)
374 (95.6)
16 (4.1)
1 (0.3)
60 (100)
44 (73.3)
15 (25)
1 (1.7)
86 (100)
71(82.6)
14 (16.3)
1 (1.1) 6.6 [3.3–13.4] 4.2 [2.1–8.4]
Mean birth weight (g),
mean (SD)
1890 (67) 1540 (71) 1780 (67) 0.93 [0.89–0.96] 0.98 [0.94–1.01]
Postnatal death, n (%):
Of 1 child
Of 2 children
Of 3 children
22 (5.6)
5 (1.3)
0 (0)
1 (1.7)
3 (5)
3 (5)
5 (5.8)
3 (3.5)
0 (0) 2.11 [1.29–3.45] 1.34 [0.77–2.34]
Apgar scores at 5 min,
mean (SD)
8.1 (1.6) 8.1 (1.7) (7.8) (1.8) 1.01 [0.85–1.21] 0.9 [0.79–1.03]
Syndrome of hyaline
membranes, n (%):
In 1 child
In 2 children
In 3 children
In 4 children
84 (21.5)
143 (36.6)
5 (1.3)
1 (0.3)
9 (15)
23 (38.3)
5 (8.3)
0 (0)
20(23.3)
19 (22.1)
8 (9.3)
1 (1.2) 1.20 [0.91–1.59] 1.01 [0.79–1.28]
Cerebral haemorrhage
In 1 child, n (%)
In 2 children, n (%)
26 (6.7)
2 (0.5)
4 (6.7)
2 (3.3)
5 (5.8)
0 ( 0) 1.64 (0.78–3.45) 0.78 (0.31–1.92)
Retinopathy, n (%):
In 1 child
In 2 children
10 (2.6)
3 (0.8)
2 (3.3)
0 (0)
1(1.2)
1(1.2) 0.85 [0.24–3.8] 0.89 [0.30–2.59]
Infection, sepsis n (%):
In 1 child
In 2 children
In 3 children
42 (10.7)
54 (13.8)
2 (0.5)
6 (10)
10 (16.7)
2 (3.3)
13 (15.1)
9 (10.5)
1 (1.2) 1.24 [0.89–1.72] 0.99 [0.72–1.36]
Postnatal persistent DAB, n (%): 29 (7.42) 10 (16.6) 11 (12.8) 2.49 [1.15–5.43] 1.83 [0.88–3.83]
Duration of hospitalisation
(days): mean (SD)
18.6 (18) 16.9 (15.4) 17.7 (16) 0.99 [0.98–1.01] 0.99 [0.98–1.01]
CI = confidence interval; DAB = ductus arteriosus Botalli; Pregn. = pregnancies; RRR = relative ride ratio; SD = standard deviation;
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Compared with the natural conception group, mean birth
weight was significantly lower only in the OS, but not in
the IVF-ICSI group.
Compared with natural conception, the number of postnatal
deaths was significantly increased after ovarian stimula-
tion, but not after IVF-ICSI.
Postnatal persistent ductus arteriosus Botalli was also sig-
nificantly higher only after ovarian stimulation.
There were no significant differences found for all the other
pathologies listed in table 2.
Multivariate analysis
Results are depicted in table 3.
Age was significantly elevated in the IVF-ICSI-group and
BMI significantly elevated in the OS-group compared with
the natural conception group.
Vaginal bleeding / placenta praevia and gestational diabetes
occurred significantly more often in the IVF-ICSI-group
compared with the natural conception group.
There were significantly more amnion infection syndromes
in the OS group.
The number of babies was significantly elevated in the OS
group (RRR 4.8) and also in the IVF-ICSI-group (RRR
3.97).
Discussion
This study examined the different aetiologies of MP at the
university Hospital Bern during a 12-year period. It shows
that there is a higher triplet rate after OS. This is confirmed
by research undertaken in other countries [15].
Another important point is that, in the current study, the
outcome of the MP after OS is worse: there are signi-
ficantly more amnion infection syndromes compared with
natural conception, babies are born at a significantly lower
gestational age, they have a significantly lower birth weight
and significantly more often a persistent ductus arteriosus
Botalli. There are also more postnatal deaths found in the
OS group.
Even though in this study there are possible biases due to a
university hospital based population, data fit well with pub-
lished literature and the origin of triplet pregnancies in this
study was similar to Swiss results [17]. This recent Swiss
study has shown that the incidence of higher-order mul-
tiple births in a 20-year interval is still increasing and suffi-
cient control and monitoring is consequently required [17].
According to this study, not only Swiss IVF-ICSI special-
ists can be made responsible for the important rise of MP
in the last decades. Ovarian stimulation treatments with/
without insemination in Switzerland are very often carried
out by physicians who are not specialised in reproductive
medicine, so they equally bear a portion of the responsib-
ility. Furthermore, MP resulting from infertility treatments
abroad are also accountable to a certain extent [17]. Con-
sequently, the origin of MP is complex and different meas-
ures have to be taken to avoid these complications.
In Belgium, for example, measures have been taken in or-
der to avoid MP after OS: OS is only possible after having
achieved a subspecialist training in reproductive medicine
at an accredited centre, as established in European coun-
tries by ESHRE (European Society of Human Reproduc-
tion and Embryology).
In order to lower the occurrence of MP in IVF-ICSI treat-
ments, the number of transferred embryos has to be re-
duced. The maintenance of equal pregnancy rates with a
concomitantly minimal risk of MP is possible with the se-
lection and culture of the best embryo and cryopreserva-
tion of the supernumerous embryos, the so called “elective
single embryo transfer” (eSET). Many studies have shown
that in defined conditions, the cumulative live births after
eSET were identical to that of transfer of 2 or even 3 em-
bryos with a dramatic decrease (<5%) in the rate of twin
pregnancies and the quasi nonexistence (<<1%) of triplets
after IVF-ICSI [18–23]. Moreover, the mean birth weight
was shown to be higher and the incidence for preterm birth/
low birth weight was clearly reduced [24]. These excel-
lent results have been so convincing that Belgium had elab-
orated a new concept since 2005: if women with clearly
defined criteria get an eSET, the IVF treatment is free of
cost for the patient. Thanks to this procedure, MP rates de-
creased and a dramatic reduction in maternal/neonatal mor-
bidity and costs for the public healthservice ensued [25].
This system stands the test of time and could be taken as a
model for other countries.
Owing to Swiss legislation, which prohibits the cryopreser-
vation of embryos, an eSET programme is not possible in
Switzerland today [16, 26]. Fortunately, a revision of the
current Swiss law plans to legalise preimplantation genet-
ic diagnosis (PGD) and the cryopreservation of embryos.
However, instead of giving Swiss infertile couples the op-
timum chance to avoid MP, the new proposal intends to
maintain the maximum number of three embryos which
could be cultured to the embryonic state (eight embryos in
the case of PGD), notwithstanding numerous explanations
by scientific experts worldwide and the Belgium success
story. It is incomprehensible that the new proposal will not
allow eSET despite scientifically proven lower complica-
tion rates and enormous savings for the Swiss health sys-
tem. In fact, this proposed “pseudo revision” of the Swiss
law would not lead to any real changes in reproductive
Table 3: Multivariate analysis.
Ovarian stimulation vs Natural conception
RRR
CI (95%)
IVF-ICSI vs Natural conception
RRR
CI (95%)
Maternal age (per 5 years) 1.11 [0.79–1.56] 2.03 [1.47–2.81]
BMI 1.06 [1–1.14] 0.98 [0.91–1.06]
Vaginal bleeding / placenta praevia 2.18 [0.96–4.48] 2.27 [1.08–4.80]
Gestational diabetes during pregnancy 1.39 [0.26–7.43] 3.85 [1.13–13.10]
Amnion infection syndrome 4.01 [1.76–9.15] 0.99 [0.37–2.70]
Number of babies 4.8 [1.95–11.82] 3.97 [1.69–9.28]
BMI = body mass index; CI = confidence interval; RRR = relative ride ratio
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medicine in Switzerland: an eSET programme would still
be impossible and PGD would quite surely not be practiced
in Switzerland, due to much higher costs for couples.
Interestingly, in August 2012, the Strasbourg-based court
ordered the Italian Government to pay 17,500 Euros to a
couple, as compensation for refusing to screen embryos for
cystic fibrosis by PGD in order to avoid abortion of an ill
child, which they had had to do twice already. An analogy
could be made with couples in Switzerland, who have IVF-
twins or -triplets with serious handicaps due to the com-
plications of prematurity. They could be legally entitled
to receive compensation from the Swiss state for refusing
elective single embryo transfer.
Current practice in infertility treatment in Switzerland is
also heavily biased by the reimbursement policy. Whereas
OS is covered by the health insurance, all IVF-ICSI treat-
ment must be paid by the infertile couples themselves. The
cost-benefit ratio of OS is questionable. In contrast, the
cost-benefit ratio of ART has been demonstrated to be in
favour of IVF-ICSI. A reversal of the present reimburse-
ment policy, together with a lift of the current ban on cryo-
preservation of embryos, would drastically modify current
practice and lower the present multiple delivery rate.
In conclusion, MP is the most important complication of
infertility treatments [2]. Our study results have shown
that more triplets originate by OS compared to IVF-ICSI
and that the neonatal outcome of multiples conceived by
OS is worse compared to spontaneous conception. In con-
trast, no significant differences concerning neonatal out-
come have been observed for neonates conceived by IVF-
ICSI. However, as MP (already twin pregnancies) have
a much higher maternal and neonatal morbidity/mortality
compared with singleton pregnancies, they have absolutely
to be avoided. Nonspecialised physicians who perform
ovarian stimulation treatments with/without insemination
should be encouraged to undergo better specialised train-
ing. On the other hand, if the Swiss law on reproductive
medicine were changed to allow eSET as an option, a dra-
matic decrease of MP after IVF-ICSI as well as enormous
cost savings in public health care would ensue [18, 24, 25,
27].
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